Guillain-?Barr Syndrome is a rare condition in which a person's immune system attacks the peripheral nerves. People affected suffer from muscle weakness and paralysis. A research team led by ETH ...
Everyday Health on MSN
What’s the difference between chronic inflammatory demyelinating polyneuropathy and Guillain-Barré syndrome?
Learn the key differences between CIDP and GBS, including causes, onset, and treatments, to ensure you get the correct ...
Maharashtra Chief Minister Devendra Fadnavis on Tuesday directed officials to make special arrangements for treating Guillain-Barre Syndrome (GBS) patients, reported the PTI. CM Devendra Fadnavis ...
Guillain-Barré Syndrome (GBS) is a rare neuromuscular condition that can cause rapid paralysis. Diagnosing GBS is challenging, and misdiagnosis can lead to delayed treatment and potentially long-term ...
Annexon (ANNX) announced topline results from a real-world evidence study supporting ANX005 as a potential treatment for Guillain-Barre Syndrome. GBS is a rapid-onset and acute neuromuscular disease ...
Annexon, Inc. (ANNX) was able to achieve positive results from its phase 3 study for the treatment of patients with Guillain-Barré syndrome [GBS]. Matter of fact, it noted that a lower dose of its ...
Patients with Guillain- Barré syndrome (GBS) face a rare and heterogeneous disorder of the peripheral nervous system that is often triggered by preceding infections and causes severe muscle weakness.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback